Prothena Corp. plc Stock
Prothena Corp. plc Stock
There is an upward development for Prothena Corp. plc compared to yesterday, with an increase of €0.20 (2.470%).
With 16 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 26 € there is potential for a 217.07% increase which would mean more than doubling the current price of 8.2 € for Prothena Corp. plc.
Our community identified positive and negative aspects for Prothena Corp. plc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Prothena Corp. plc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | 2.470% | 1.235% | -8.889% | -43.448% | -43.448% | -85.268% | -18.812% |
| Ardelyx Inc. | -1.080% | -0.244% | -3.002% | -1.067% | -1.067% | 106.821% | -14.929% |
| Krystal Biotech | 0.970% | 0.790% | 14.648% | 42.444% | 42.444% | 189.067% | - |
| Evolus Inc | -4.390% | -3.390% | -4.202% | -45.714% | -45.714% | -16.788% | 115.176% |
Comments
Prothena (NASDAQ:PRTA) had its price target raised by analysts at HC Wainwright from $20.00 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target lowered by analysts at Piper Sandler from $81.00 to $15.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat